Fig 5.
Pattern of ex vivo PARP inhibition observed in PBLs from patient treated with a PARP inhibitory dose of AG-014699 27.8 mg (12 mg/m2). Abbreviations: PAR, poly(ADP)-ribose; PBL, peripheral blood lymphocytes.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.